A multi-paper research program · Vascular Neuroscience · PTSD
Cerebrovascular receptor density remodeling as a substrate for PTSD chronicity
Experience-dependent remodeling of the cerebrovascular receptor landscape constitutes a previously unrecognized substrate for the chronicity of posttraumatic stress disorder. What the vasculature learns, it encodes structurally — and what learning produced, learning should be capable of undoing.
The Framework
The DVA hypothesis does not replace existing PTSD neuroscience. Amygdala hyperreactivity, mPFC hyporesponsiveness, and HPA axis sensitization are established findings the framework accepts entirely. It proposes a level beneath these findings — the cerebrovascular receptor landscape — that existing accounts have not examined. Every finding in the existing literature remains valid. The framework adds a floor beneath it.
Amygdala-serving and mPFC-serving cerebrovascular beds differ systematically in baseline receptor composition, producing opposite regional blood flow responses to the same stress hormone signal. The DVA is the gatekeeper assumption on which the framework depends.
Experience-dependent, durable alteration in receptor density at the vessel wall that changes future perfusion and permeability responses to the same circulating signals. A structural encoding of the frequency and intensity of prior activation states — threat-dominant or safety-dominant.
The self-maintaining loop in which trauma memory retrieval — the process that should reverse PTSD — is specifically impaired by the vascular substrate the disorder has produced. The act of remembering becomes a mechanism of chronification.
A novel therapeutic target class: any intervention that modifies the receptor density profile of the cerebrovascular bed in a clinically targeted direction, producing durable change toward safety-dominant perfusion and permeability characteristics.
Project-coined constructs
The Research Program
The framework generates nine predictions organized across preclinical, human imaging, and treatment response phases. These predictions are additions to the empirical agenda, not replacements for existing accounts. Each is falsifiable, specific, and distinguishable from what existing frameworks would predict.
Circuit-specific cerebrovascular receptor density heterogeneity in stress-conditioned rodents. If this fails, the strong formulation fails with it.
Receptor density remodeling shows a dose-response relationship with stress exposure history, with incomplete reversal consistent with asymmetric hysteresis.
Circuit-specific CBF asymmetry correlates with receptor density asymmetry under acute catecholamine challenge, establishing the structural-functional link.
Resting-state ASL perfusion asymmetry in chronic PTSD populations, persisting when task-based activation has normalized — the signature of a vascular contribution.
Pharmacological challenge (α1-adrenergic agonist) produces greater regional perfusion differential in chronic PTSD participants, correlating with chronification severity.
One-month post-trauma ASL asymmetry predicts six-month mPFC fMRI activation — temporal precedence across the chronification trajectory.
Resting-state perfusion asymmetry at treatment entry predicts response to exposure-based therapy independently of symptom severity.
Partial responders show task-based fMRI normalization in the absence of resting ASL normalization — a residual vascular asymmetry predicting relapse.
Pharmacological TVDM augmentation produces greater resting ASL normalization than placebo, mediating enhanced treatment response. Prazosin is the most immediately feasible candidate.
Priority collaboration need
Circuit-specific cerebrovascular receptor density measurement (rodent models) — the direct test of Prediction 1 — is the highest-priority empirical need in the project. Ultra-high-field ASL imaging with pharmacological challenge capability is the highest-priority human imaging need.
The Team
MSW, LCSW · LifeLong Medical Care · Advisor, Alexander Shulgin Research Institute · Fulbright Specialist
MD · Vascular Neurology · Arterial Spin Labelling Imaging
PA-C · George Washington University · Clinical and Translational Perspective
MD, PhD · NORMENT, University of Oslo · Psychedelic Pharmacology and Clinical Research
Technical Editor · Developed theoretical extensions, adversarial peer review, and architectural coherence across the manuscript development process
The project is actively recruiting collaborators in cerebrovascular receptor density measurement, ultra-high-field ASL imaging, stress-conditioned rodent cerebrovascular biology, neuroinflammation and BBB disruption in trauma populations, psychedelic pharmacology, pediatric cerebrovascular neuroscience, and plain-language and translation contributions. See joining information →
Publications
Available from the corresponding author on request · jakeim@lifelongmedical.org
The Collaboration Model
The theoretical framework at the center of this project was developed through an extended series of collaborative sessions between the initiating author and Claude (Anthropic), functioning as Collaborative Theoretical Architect and Technical Editor. The generative source is human. The collaborative elaboration is genuinely joint.
What began as an image without words became, across twenty minutes of collaborative exchange, the mechanical analogy now anchoring the paper's foundational section — and a prompt that generated an independent engineering analysis confirming asymmetric hysteresis, strain-gated permeability transitions, and structural encoding of activation history as consequences of the same mechanism.
How to Contribute
Joining does not require agreeing to co-authorship. It requires only interest. Contribution is welcomed at whatever level current availability permits. Co-authorship on a specific paper is a decision made when a specific contribution is ready — not a commitment required at entry.
Contact
When contacting the project about a spoke paper, please use the subject line: VLP Spoke Paper — [brief description]